Predictors for mild parkinsonian signs: A prospective population-based study

Parkinsonism and Related Disorders

Volumn 21, Issue 3, 2015, Pages 321-324

  Mahlknecht, Philipp ^a,b   Kiechl, Stefan ^a   Stockner, Heike ^a   Willeit, Johann ^a   Gasperi, Arno ^c   Poewe, Werner ^a   Seppi, Klaus ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c Hospital of Bruneck   (Italy)

Author keywords

Mild parkinsonian signs; Olfactory dysfunction; Substantia nigra echogenicity; Transcranial ultrasound; Vascular risk factors

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BRADYKINESIA; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENDER; HIGH RISK POPULATION; HUMAN; HYPOSMIA; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; PARKINSONISM; PRIORITY JOURNAL; PROSPECTIVE STUDY; RIGIDITY; RISK FACTOR; SUBSTANTIA NIGRA; TREMOR; VERY ELDERLY; COHORT ANALYSIS; DOPPLER ECHOGRAPHY; HEALTH CARE PLANNING; NONPARAMETRIC TEST; PARKINSON DISEASE; PATHOPHYSIOLOGY; PREDICTIVE VALUE; STATISTICAL MODEL;

AGED; AGED, 80 AND OVER; COHORT STUDIES; COMMUNITY HEALTH PLANNING; FEMALE; HUMANS; LOGISTIC MODELS; MALE; PARKINSON DISEASE; PREDICTIVE VALUE OF TESTS; STATISTICS, NONPARAMETRIC; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 84923261507     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2014.12.021     Document Type: Article

References (16)

1. Louis E.D., Bennett D.A. Mild parkinsonian signs: an overview of an emerging concept. Mov Disord 2007, 22:1681-1688.
2. Berg D., Godau J., Seppi K., Behnke S., Liepelt-Scarfone I., Lerche S., et al. The PRIPS study: screening battery for subjects at risk for Parkinson's disease. Eur J Neurol 2013, 20:102-108.
3. Louis E.D., Tang M.X., Schupf N. Mild parkinsonian signs are associated with increased risk of dementia in a prospective, population-based study of elders. Mov Disord 2010, 25:172-178.
4. Buchman A.S., Shulman J.M., Nag S., Leurgans S.E., Arnold S.E., Morris M.C., et al. Nigral pathology and parkinsonian signs in elders without Parkinson disease. Ann Neurol 2012, 71:258-266.
5. Berg D., Becker G., Zeiler B., Tucha O., Hofmann E., Preier M., et al. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 1999, 53:1026-1031.
6. Postuma R.B., Aarsland D., Barone P., Burn D.J., Hawkes C.H., Oertel W., et al. Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease. Mov Disord 2012, 27:617-626.
7. Wilson R.S., Arnold S.E., Buchman A.S., Tang Y., Bennett D.A. Odor identification and progression of parkinsonian signs in older persons. Exp Aging Res 2008, 34:173-187.
8. Mahlknecht P., Seppi K., Stockner H., Nocker M., Scherfler C., Kiechl S., et al. Substantia nigra hyperechogenicity as a marker for Parkinson's disease: a population-based study. Neurodegener Dis 2013, 12:212-218.
9. Mahlknecht P., Stockner H., Nocker M., Kiechl S., Willeit J., Scherfler C., et al. Afollow-up study of substantia nigra echogenicity in healthy adults. Mov Disord 2012, 27:1196-1197.
10. D'Agostino R.B., Vasan R.S., Pencina M.J., Wolf P.A., Cobain M., Massaro J.M., et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008, 117:743-753.
11. de Laat K.F., van Norden A.G., Gons R.A., van Uden I.W., Zwiers M.P., Bloem B.R., et al. Cerebral white matter lesions and lacunar infarcts contribute to the presence of mild parkinsonian signs. Stroke 2012, 43:2574-2579.
12. Shulman J.M., Yu L., Buchman A.S., Evans D.A., Schneider J.A., Bennett D.A., et al. Association of Parkinson disease risk loci with mild parkinsonian signs in older persons. JAm Med Assoc Neurol 2014, 71:429-435.
13. Wilson R., Arnold S.E., Schneider J.A., Tang Y., Bennett D.A. The relationship between cerebral Alzheimer's disease pathology and odour identification in old age. JNeurol Neurosurg Psychiatry 2007, 78:30-35.
14. Mahlknecht P., Kiechl S., Bloem B.R., Willeit J., Scherfler C., Gasperi A., et al. Prevalence and burden of gait disorders in elderly men and women aged 60-97 years: a population-based study. PLoS One 2013 Jul 24, 8:e69627.
15. Verghese J., Annweiler C., Ayers E., Barzilai N., Beauchet O., Bennett D.A., et al. Motoric cognitive risk syndrome: multicountry prevalence and dementia risk. Neurology 2014, 83:718-726.
16. Buchman A.S., Leurgans S.E., Nag S., Bennett D.A., Schneider J.A. Cerebrovascular disease pathology and parkinsonian signs in old age. Stroke 2011, 42:3183-3189.